Capstone Investment Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$354K Buy
+3,005
New +$420K ﹤0.01% 1301
2025
Q4
Sell
-4,711
Closed -$630K 1970
2025
Q3
$630K Buy
+4,711
New +$572K ﹤0.01% 1243
2024
Q2
Sell
-1,831
Closed -$337K 2399
2024
Q1
$337K Buy
+1,831
New +$349K ﹤0.01% 1772
2021
Q4
Sell
-3,473
Closed -$1M 2055
2021
Q3
$1M Buy
+3,473
New +$891K ﹤0.01% 1400
2017
Q4
Sell
-13,763
Closed -$527K 628
2017
Q3
$527K Buy
+13,763
New +$577K 0.02% 310
2017
Q1
Sell
-7,900
Closed -$243K 1079
2016
Q4
$243K Buy
+7,900
New +$244K 0.01% 777

Other funds holding RGEN

Capstone Investment Advisors's RGEN Position: Q1 2026 in Review

Capstone Investment Advisors opened a new position in Repligen (RGEN) in Q1 2026: 3,005 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #1301 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in RGEN as recently as Q3 2025.

Capstone Investment Advisors first reported a position in RGEN in Q4 2016 and has held it in 6 quarters since. The position peaked at $1M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Capstone Investment Advisors held 3,005 shares of Repligen worth $354K as of Q1 2026.
  • Repligen was a new Capstone Investment Advisors position in Q1 2026.
  • Repligen made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1301 holding.
  • Capstone Investment Advisors first reported a position in Repligen in Q4 2016 and has held it in 6 quarters since.
  • Capstone Investment Advisors's Repligen position peaked at $1M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.